Kelonia

Acquired

Kelonia is a biotech company in Boston, United States, founded in 2021. It has raised $50.0M across 1 round, most recently a $50.0M Series A in April 2022.

Delivering on the Promise of Genetic Medicine

Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$50.0M
Last Round
$50.0M Series AApr 2022
Rounds
1
Acquisition Date
Apr 2026

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Kelonia Therapeutics is a clinical-stage gene therapy company headquartered in Boston, Massachusetts, focused on in vivo gene delivery to advance a new era of genetic medicines. Founded in 2021, Kelonia is developing proprietary delivery platforms designed to address a broad range of genetic diseases with greater accessibility and scalability than ex vivo approaches. The company's pipeline targets diseases amenable to gene correction, with preclinical and early clinical programs spanning oncology and rare genetic conditions. Kelonia is led by founder and CEO Kevin Friedman, PhD, and backed by investors including Alta Partners and Venrock. The company has assembled a multidisciplinary team of scientists, clinicians, and industry veterans from leading pharma and biotech organizations.

Summary

It lists 11–50 employees. It has raised $50.0M in total across 1 round, most recently a $50.0M Series A round in Apr 2022. Investors include Eli Lilly.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
AcquisitionApr 2026

Sign up to see all 2 events

Funding: Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Kelonia on Indexed.vc
<a href="https://indexed.vc/companies/kelonia"><img src="https://indexed.vc/api/badge/company/kelonia" alt="Kelonia on Indexed.vc" width="260" height="76" /></a>